Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Open accessThe DOI matches its Crossref record; 537 of the 537 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Its complexity is influenced by various signal transduction networks that govern cellular proliferation, survival, differentiation, and apoptosis. The pathogenesis of CRC is a testament to the dysregulation of these signaling cascades, which culminates in the malignant transformation of colonic epithelium. This review aims to dissect the foundational signaling mechanisms implicated in CRC, to elucidate the generalized principles underpinning neoplastic evolution and progression. We discuss the molecular hallmarks of CRC, including the genomic, epigenomic and microbial features of CRC to highlight the role of signal transduction in the orchestration of the tumorigenic process. Concurrently, we review the advent of targeted and immune therapies in CRC, assessing their impact on the current clinical landscape. The development of these therapies has been informed by a deepening understanding of oncogenic signaling, leading to the identification of key nodes within these networks that can be exploited pharmacologically. Furthermore, we explore the potential of integrating AI to enhance the precision of therapeutic targeting and patient stratification, emphasizing their role in personalized medicine. In summary, our review captures the dynamic interplay between aberrant signaling in CRC pathogenesis and the concerted efforts to counteract these changes through targeted therapeutic strategies, ultimately aiming to pave the way for improved prognosis and personalized treatment modalities in colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, HER2 is commonly amplified or overexpressed in 7% to 47.4% of CRC patients, activating downstream signaling in a similar manner [81–83].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [81]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 537
Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma
Qin, M., Liu, G., Huo, X., Tao, X., Sun, X., Ge, Z., Yang, J., Fan, J., Liu, L., & Qin, W. (2016) · Cancer Biomarkers · doi:10.3233/cbm-150552 · Cited by 441
Tsoi, H., Chu, E. S. H., Zhang, X., Sheng, J., Nakatsu, G., Ng, S. C., Chan, A. W. H., Chan, F. K. L., Sung, J. J. Y., & Yu, J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.009 · Cited by 438
Self-citationBrenner, H., Hoffmeister, M., Stegmaier, C., Brenner, G., Altenhofen, L., & Haug, U. (2007) · Gut · doi:10.1136/gut.2007.122739 · Cited by 438
Yang, D., Elner, S. G., Bian, Z.-M., Till, G. O., Petty, H. R., & Elner, V. M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.06.013 · Cited by 438
Luo, H., Zhao, Q., Wei, W., Zheng, L., Yi, S., Li, G., Wang, W., Sheng, H., Pu, H., Mo, H., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7533 · Cited by 437
Self-citationJackstadt, R., van Hooff, S. R., Leach, J. D., Cortes-Lavaud, X., Lohuis, J. O., Ridgway, R. A., Wouters, V. M., Roper, J., Kendall, T. J., Roxburgh, C. S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.003 · Cited by 433
Li, H., Chiappinelli, K. B., Guzzetta, A. A., Easwaran, H., Yen, R.-W. C., Vatapalli, R., Topper, M. J., Luo, J., Connolly, R. M., Azad, N. S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1782 · Cited by 430
Imai, K., & Yamamoto, H. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm228 · Cited by 429
Sullivan, R. J., Infante, J. R., Janku, F., Wong, D. J. L., Sosman, J. A., Keedy, V., Patel, M. R., Shapiro, G. I., Mier, J. W., Tolcher, A. W., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1119 · Cited by 426
Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility
Uronis, J. M., Mühlbauer, M., Herfarth, H. H., Rubinas, T. C., Jones, G. S., & Jobin, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006026 · Cited by 425
Bile acids as modulators of gut microbiota composition and function
Larabi, A. B., Masson, H. L. P., & Bäumler, A. J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2172671 · Cited by 401
Jones, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2961 · Cited by 400
Modulating extracellular matrix stiffness: A strategic approach to boost cancer immunotherapy
Mai, Z., Lin, Y., Lin, P., Zhao, X., & Cui, L. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06697-4 · Cited by 398
Artificial Intelligence-Assisted Polyp Detection for Colonoscopy: Initial Experience
Misawa, M., Kudo, S.-E., Mori, Y., Cho, T., Kataoka, S., Yamauchi, A., Ogawa, Y., Maeda, Y., Takeda, K., Ichimasa, K., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.003 · Cited by 394
Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia
Crockett, S. D., & Nagtegaal, I. D. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.041 · Cited by 393
Yamashita, R., Long, J., Longacre, T., Peng, L., Berry, G., Martin, B., Higgins, J., Rubin, D. L., & Shen, J. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30535-0 · Cited by 391
Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes
Nakatsu, G., Zhou, H., Wu, W. K. K., Wong, S. H., Coker, O. O., Dai, Z., Li, X., Szeto, C.-H., Sugimura, N., Lam, T. Y.-T., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.018 · Cited by 386
Emerging Cellular Therapies for Cancer
Guedan, S., Ruella, M., & June, C. H. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041407 · Cited by 386
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., & Lyko, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2821 · Cited by 385
Proffitt, K. D., Madan, B., Ke, Z., Pendharkar, V., Ding, L., Lee, M. A., Hannoush, R. N., & Virshup, D. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2258 · Cited by 382
Middha, S., Zhang, L., Nafa, K., Jayakumaran, G., Wong, D., Kim, H. R., Sadowska, J., Berger, M. F., Delair, D. F., Shia, J., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00084 · Cited by 377
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning
Echle, A., Grabsch, H. I., Quirke, P., van den Brandt, P. A., West, N. P., Hutchins, G. G. A., Heij, L. R., Tan, X., Richman, S. D., Krause, J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.021 · Cited by 376
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Cancer Risk in Relatives of Patients with Common Colorectal Cancer
St. John, D. J. B., McDermott, F. T., Hopper, J. L., Debney, E. A., Johnson, W. R., & Hughes, E. S. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00005 · Cited by 368
Weichert, W., Röske, A., Niesporek, S., Noske, A., Buckendahl, A.-C., Dietel, M., Gekeler, V., Boehm, M., Beckers, T., & Denkert, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0990 · Cited by 361
Current progress and open challenges for applying deep learning across the biosciences
Sapoval, N., Aghazadeh, A., Nute, M. G., Antunes, D. A., Balaji, A., Baraniuk, R., Barberan, C. J., Dannenfelser, R., Dun, C., Edrisi, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29268-7 · Cited by 359
Reddy, B. S., & Rivenson, A. (1993) · PubMed · Cited by 357
Deep Learning in Medical Imaging
Kim, M., Yun, J., Cho, Y., Shin, K., Jang, R., Bae, H.-J., & Kim, N. (2019) · Neurospine · doi:10.14245/ns.1938396.198 · Cited by 351
Deep learning for classification of colorectal polyps on whole-slide images
Korbar, B., Olofson, A. M., Miraflor, A. P., Nicka, C. M., Suriawinata, M. A., Torresani, L., Suriawinata, A. A., & Hassanpour, S. (2017) · Journal of Pathology Informatics · doi:10.4103/jpi.jpi_34_17 · Cited by 349
Next-generation sequencing in the clinic: Promises and challenges
Xuan, J., Yu, Y., Qing, T., Guo, L., & Shi, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.025 · Cited by 344
Assembly and function of a bacterial genotoxin
Nešić, D., Hsu, Y., & Stebbins, C. E. (2004) · Nature · doi:10.1038/nature02532 · Cited by 343
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
Madan, B., Ke, Z., Harmston, N., Ho, S. Y., Frois, A. O., Alam, J., Jeyaraj, D. A., Pendharkar, V, Ghosh, K., Virshup, I. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.280 · Cited by 341
Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3
Jura, N., Shan, Y., Cao, X., Shaw, D. E., & Kuriyan, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912101106 · Cited by 338
The future of epigenetic therapy in solid tumours—lessons from the past
Azad, N., Zahnow, C. A., Rudin, C. M., & Baylin, S. B. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.42 · Cited by 335
Dou, Y., Cha, D. J., Franklin, J. L., Higginbotham, J. N., Jeppesen, D. K., Weaver, A. M., Prasad, N., Levy, S., Coffey, R. J., Patton, J. G., et al. (2016) · Scientific Reports · doi:10.1038/srep37982 · Cited by 328
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
Wensink, G. E., Elias, S. G., Mullenders, J., Koopman, M., Boj, S. F., Kranenburg, O. W., & Roodhart, J. M. L. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00168-1 · Cited by 323
Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer
Enriquez-Navas, P. M., Kam, Y., Das, T., Hassan, S., Silva, A., Foroutan, P., Ruiz, E., Martinez, G., Minton, S., Gillies, R. J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7842 · Cited by 322
Fakih, M. G., Kopetz, S., Kuboki, Y., Kim, T. W., Munster, P. N., Krauss, J. C., Falchook, G. S., Han, S.-W., Heinemann, V., Muro, K., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00605-7 · Cited by 320
Rowland, A., Dias, M. M., Wiese, M. D., Kichenadasse, G., McKinnon, R. A., Karapetis, C. S., & Sorich, M. J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.173 · Cited by 319
Combining Epigenetic and Immunotherapy to Combat Cancer
Chiappinelli, K. B., Zahnow, C. A., Ahuja, N., & Baylin, S. B. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2125 · Cited by 309
Chung, K. Y., Gore, I., Fong, L., Venook, A., Beck, S. B., Dorazio, P., Criscitiello, P. J., Healey, D. I., Huang, B., Gomez-Navarro, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.3994 · Cited by 306
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment
Kavuri, S. M., Jain, N., Galimi, F., Cottino, F., Leto, S. M., Migliardi, G., Searleman, A. C., Shen, W., Monsey, J., Trusolino, L., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1211 · Cited by 302
Pai-Scherf, L., Blumenthal, G. M., Li, H., Subramaniam, S., Mishra-Kalyani, P. S., He, K., Zhao, H., Yu, J., Paciga, M., Goldberg, K. B., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0078 · Cited by 294
YAP/TAZ link cell mechanics to Notch signalling to control epidermal stem cell fate
Totaro, A., Castellan, M., Battilana, G., Zanconato, F., Azzolin, L., Giulitti, S., Cordenonsi, M., & Piccolo, S. (2017) · Nature Communications · doi:10.1038/ncomms15206 · Cited by 292
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
Qi, S.-M., Dong, J., Xu, Z.-Y., Cheng, X.-D., Zhang, W.-D., & Qin, J.-J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.692574 · Cited by 292
Neto-Silva, R. M., de Beco, S., & Johnston, L. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.009 · Cited by 287
Schulz, D., Zanotelli, V. R. T., Fischer, J. R., Schapiro, D., Engler, S., Lun, X.-K., Jackson, H. W., & Bodenmiller, B. (2018) · Cell Systems · doi:10.1016/j.cels.2017.12.001 · Cited by 280
Probiotics for the Prevention of Antibiotic‐Associated Diarrhea in Children
Szajewska, H., Canani, R. B., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Shamir, R., Vandenplas, Y., van Goudoever, J. B., et al. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001081 · Cited by 268
Cappuzzo, F., Finocchiaro, G., Rossi, E., Jänne, P. A., Carnaghi, C., Calandri, C., Bencardino, K., Ligorio, C., Ciardiello, F., Pressiani, T., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm492 · Cited by 267
Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon
Hardwick, J. C. H., Van Den Brink, G. R., Bleuming, S. A., Ballester, I., Van Den Brande, J. M. H., Keller, J. J., Offerhaus, G. J. A., Van Deventer, S. J. H., & Peppelenbosch, M. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.067 · Cited by 261
Sartore-Bianchi, A., Di Nicolantonio, F., Nichelatti, M., Molinari, F., De Dosso, S., Saletti, P., Martini, M., Cipani, T., Marrapese, G., Mazzucchelli, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007287 · Cited by 259
Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm0715-827b · Cited by 255
Morelli, M. P., Overman, M. J., Dasari, A., Kazmi, S. M. A., Mazard, T., Vilar, E., Morris, V. K., Lee, M. S., Herron, D., Eng, C., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv005 · Cited by 254
Masui, H., Kawamoto, T., Sato, J. D., Wolf, B., SATO, G. H., & Mendelsohn, J. (1984) · PubMed · Cited by 254
AMPK: A Contextual Oncogene or Tumor Suppressor?
Liang, J., & Mills, G. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3876 · Cited by 252
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
Siena, S., Sartore-Bianchi, A., Marsoni, S., Hurwitz, H. I., McCall, S. J., Penault-Llorca, F., Srock, S., Bardelli, A., & Trusolino, L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy100 · Cited by 244
Artificial Intelligence-assisted System Improves Endoscopic Identification of Colorectal Neoplasms
Kudo, S.-E., Misawa, M., Mori, Y., Hotta, K., Ohtsuka, K., Ikematsu, H., Saito, Y., Takeda, K., Nakamura, H., Ichimasa, K., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.09.009 · Cited by 242
Jakobsen, S. N., Hardie, D. G., Morrice, N., & Tornqvist, H. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100483200 · Cited by 238
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
Suzuki, H., Toyota, M., Caraway, H., Gabrielson, E., Ohmura, T., Fujikane, T., Nishikawa, N., Sogabe, Y., Nojima, M., Sonoda, T., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604259 · Cited by 238
Witcher, M., & Emerson, B. M. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.001 · Cited by 235
Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (Review)
Katoh (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000019 · Cited by 234
Rowland, A., Dias, M. M., Wiese, M. D., Kichenadasse, G., McKinnon, R. A., Karapetis, C. S., & Sorich, M. J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.325 · Cited by 229
Germline MutY Human Homologue Mutations and Colorectal Cancer: A Multisite Case-Control Study
Cleary, S. P., Cotterchio, M., Jenkins, M. A., Kim, H., Bristow, R., Green, R., Haile, R., Hopper, J. L., LeMarchand, L., Lindor, N., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.050 · Cited by 228
Nieuwenhuis, M. H., Casparie, M., Mathus‐Vliegen, L. M. H., Dekkers, O. M., Hogendoorn, P. C. W., & Vasen, H. F. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25664 · Cited by 224
Viral vector-based therapeutic cancer vaccines
Larocca, C., & Schlom, J. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182325e63 · Cited by 222
Lombardo, Y., Scopelliti, A., Cammareri, P., Todaro, M., Iovino, F., Ricci–Vitiani, L., Gulotta, G., Dieli, F., de Maria, R., & Stassi, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.005 · Cited by 222
Wang, L., Baudhuin, L. M., Boardman, L. A., Steenblock, K. J., Petersen, G. M., Halling, K. C., French, A. J., Johnson, R. A., Burgart, L. J., Rabe, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.070 · Cited by 218
Self-citationYang, L., Li, A., Lei, Q., & Zhang, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0804-8 · Cited by 215
Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis
Lee, S. H., Jeong, D., Han, Y.-S., & Baek, M. J. (2015) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2015.89.1.1 · Cited by 210
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Zadra, G., Photopoulos, C., Tyekucheva, S., Heidari, P., Weng, Q. P., Fedele, G., Liu, H., Scaglia, N., Priolo, C., Sicinska, E., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302734 · Cited by 204
DNA Vaccines: Developing New Strategies against Cancer
Fioretti, D., Iurescia, S., Fazio, V. M., & Rinaldi, M. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/174378 · Cited by 202
Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer
Senzer, N., Barve, M., Kuhn, J., Melnyk, A., Beitsch, P., Lazar, M., Lifshitz, S., Magee, M., Oh, J., Mill, S. W., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.269 · Cited by 198
Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
Kazanets, A., Shorstova, T., Hilmi, K., Marques, M., & Witcher, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.04.001 · Cited by 195
Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats.
Reddy, B. S., Narisawa, T., Wright, P., Vukusich, D., Weisburger, J. H., & Wynder, E. L. (1975) · PubMed · Cited by 193
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
Zak, J., Pratumchai, I., Marro, B. S., Marquardt, K. L., Zavareh, R. B., Lairson, L. L., Oldstone, M. B. A., Varner, J. A., Hegerova, L., Cao, Q., et al. (2024) · Science · doi:10.1126/science.ade8520 · Cited by 193
Mao, C., Yang, Z. Y., Hu, X. F., Chen, Q., & Tang, J. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr464 · Cited by 188
Newman, J. H., Chesson, C. B., Herzog, N. L., Bommareddy, P. K., Aspromonte, S. M., Pepe, R., Estupinian, R., Aboelatta, M. M., Buddhadev, S., Tarabichi, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904022116 · Cited by 187
A Review Paper about Deep Learning for Medical Image Analysis
Sistaninejhad, B., Rasi, H., & nayeri, P. (2023) · Computational and Mathematical Methods in Medicine · doi:10.1155/2023/7091301 · Cited by 187
Narasimhan, V., Wright, J. A., Churchill, M., Wang, T., Rosati, R., Lannagan, T. R. M., Vrbanac, L., Richardson, A. B., Kobayashi, H., Price, T., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0073 · Cited by 185
Cancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy
Liu, Y., & Zeng, G. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182518e83 · Cited by 185
Shen, L., Catalano, P. J., Benson, A. B., O'Dwyer, P., Hamilton, S. R., & Issa, J.-P. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1011 · Cited by 184
CAR T‐cell therapy: Full speed ahead
Sermer, D., & Brentjens, R. (2019) · Hematological Oncology · doi:10.1002/hon.2591 · Cited by 183
Wong, C. C., Xu, J., Bian, X., Wu, J.-L., Kang, W., Qian, Y., Li, W., Chen, H., Gou, H., Liu, D., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.016 · Cited by 179
Casak, S. J., Marcus, L., Fashoyin-Aje, L., Mushti, S. L., Cheng, J., Shen, Y.-L., Pierce, W. F., Her, L., Goldberg, K. B., Theoret, M. R., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0557 · Cited by 179
Morse, M. A., Nair, S. K., Mosca, P. J., Hobeika, A. C., Clay, T. M., Deng, Y., Boczkowski, D., Proia, A., Neidzwiecki, D., Clavien#, P.-A., et al. (2003) · Cancer Investigation · doi:10.1081/cnv-120018224 · Cited by 177
HGF Rescues Colorectal Cancer Cells from EGFR Inhibition via MET Activation
Liska, D., Chen, C.-T., Bachleitner-Hofmann, T., Christensen, J. G., & Weiser, M. R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0568 · Cited by 176
Epigenetic Modifications in Double-Strand Break DNA Damage Signaling and Repair
Rossetto, D., Truman, A. W., Kron, S. J., & Côté, J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0513 · Cited by 176
Colorectal Cancer Disparity in African Americans
Augustus, G. J., & Ellis, N. A. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.07.023 · Cited by 176
LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer
Ding, J., Zhang, Z.-M., Xia, Y., Liao, G.-Q., Pan, Y., Liu, S., Zhang, Y., & Yan, Z.-S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.364 · Cited by 175
Lynch Syndrome Genetics and Clinical Implications
Peltomäki, P., Nyström, M., Mecklin, J.-P., & Seppälä, T. T. (2023) · Gastroenterology · doi:10.1053/j.gastro.2022.08.058 · Cited by 173
Payne, C. M., Weber, C., Crowley-Skillicorn, C., Dvorak, K., Bernstein, H., Bernstein, C., Holubec, H., Dvorakova, B., & Garewal, H. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl139 · Cited by 166
Gribben, J. G., Ryan, D. P., Boyajian, R., Urban, R. G., Hedley, M. L., Beach, K., Nealon, P., Matulonis, U., Campos, S., Gilligan, T. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2111 · Cited by 165
Genome-wide association study of colorectal cancer identifies six new susceptibility loci
Schumacher, F. R., Schmit, S. L., Jiao, S., Edlund, C. K., Wang, H., Zhang, B., Hsu, L., Huang, S.-C., Fischer, C. P., Harju, J. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8138 · Cited by 165
Somatic APC mosaicism: an underestimated cause of polyposis coli
Hes, F. J., Nielsen, M., Bik, E. C., Konvalinka, D., Wijnen, J. T., Bakker, E., Vasen, H. F. A., Breuning, M. H., & Tops, C. M. J. (2008) · Gut · doi:10.1136/gut.2006.117796 · Cited by 162
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
Pothuraju, R., Rachagani, S., Krishn, S. R., Chaudhary, S., Nimmakayala, R. K., Siddiqui, J. A., Ganguly, K., Lakshmanan, I., Cox, J. L., Mallya, K., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01156-y · Cited by 160
Shahab Uddin, M. S., Ahmed, M., Hussain, A. R., Abubaker, J. A., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H. S., Alhomoud, S. J., Al‐Dayel, F., Jehan, Z., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.020 · Cited by 159
Status of PI3K inhibition and biomarker development in cancer therapeutics
Markman, B., Atzori, F., Pérez-García, J., Tabernero, J., & Baselga, J. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp347 · Cited by 159
Boland, C. R., & Lynch, H. T. (2013) · Familial Cancer · doi:10.1007/s10689-013-9637-8 · Cited by 158
Zhai, J., Chen, H., Wong, C. C., Peng, Y., Gou, H., Zhang, J., Pan, Y., Chen, D., Lin, Y., Wang, S., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.04.032 · Cited by 158
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Wang, B., Pei, J., Xu, S., Liu, J., & Yu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1246682 · Cited by 158
Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies
Petitprez, F., Vano, Y. A., Becht, É., Giraldo, N. A., de Reyniès, A., Sautès‐Fridman, C., & Fridman, W. H. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2058-z · Cited by 157
Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
Prossomariti, A., Piazzi, G., Alquati, C., & Ricciardiello, L. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.007 · Cited by 155
Foran, E., Garrity-Park, M. M., Mureau, C., Newell, J., Smyrk, T. C., Limburg, P. J., & Egan, L. J. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0496 · Cited by 155
Liu, Y., Wong, C. C., Ding, Y., Gao, M., Wen, J., Lau, H. C.-H., Cheung, A. H. K., Huang, D., Huang, H., & Yu, J. Q. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01695-w · Cited by 152
Diamond, J. R., Becerra, C., Richards, D., Mita, A., Osborne, C., O’Shaughnessy, J., Zhang, C., Henner, R., Kapoun, A. M., Xu, L., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05817-w · Cited by 152
Troiani, T., Martinelli, E., Napolitano, S., Vitagliano, D., Ciuffreda, L. P., Costantino, S., Morgillo, F., Capasso, A., Sforza, V., Nappi, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0423 · Cited by 150
Goel, B., Tiwari, A. K., Pandey, R., Singh, A. P., Kumar, S., Sinha, A., Jain, S. K., & Khattri, A. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101426 · Cited by 149
Zheng, X., Xu, K., Zhou, B., Chen, T., Huang, Y., Li, Q., Wen, F., Ge, W., Wang, J., Yu, S., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1750202 · Cited by 148
Self-citationCarcinogen-Induced Chromosomal Breakage Decreased by Antioxidants
Shamberger, R. J., Baughman, F. F., Kalchert, S. L., Willis, C. E., & Hoffman, G. C. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.5.1461 · Cited by 148
Kowalzik, F., Schreiner, D., Jensen, C., Teschner, D., Gehring, S., & Zepp, F. (2021) · Vaccines · doi:10.3390/vaccines9040390 · Cited by 147
Effect of Cytarabine and Decitabine in Combination in Human Leukemic Cell Lines
Qin, T., Youssef, E. M., Jelínek, J., Chen, R., Yang, A. S., Garcia‐Manero, G., & Issa, J. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2762 · Cited by 147
UYLDEGROOT, C., Vermorken, J. B., HannaJr., M. G., Verboom, P., Groot, M., Bonsel, G. J., Meijer, C. J. L. M., & Pinedo, H. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.015 · Cited by 146
Hou, A., Hou, K., Huang, Q., Lei, Y., & Chen, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00783 · Cited by 145
Congenital Hypertrophy of the Retinal Pigment Epithelium
Buettner, H. (1975) · American Journal of Ophthalmology · doi:10.1016/0002-9394(75)90069-0 · Cited by 144
Tanaka, T. (2012) · International Journal of Inflammation · doi:10.1155/2012/658786 · Cited by 143
Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
Wagner, S., Mullins, C. S., & Linnebacher, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i48.5418 · Cited by 142
Enholm, S., Hienonen, T., Suomalainen, A., Lipton, L. R., Tomlinson, I. P. M., Kärjä, V. J., Eskelinen, M. J., Mecklin, J., Karhu, A., Järvinen, H., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63443-8 · Cited by 142
Histone deacetylase inhibitors in cancer therapy
Lee, M.-J., Kim, Y. S., Kummar, S., Giaccone, G., & Trepel, J. B. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283127095 · Cited by 141
Prospective experimental treatment of colorectal cancer patients based on organoid drug responses
Ooft, S. N., Weeber, F., Schipper, L., Dijkstra, K. K., McLean, C. M., Kaing, S., van de Haar, J., Prevoo, W., van Werkhoven, E., Snaebjornsson, P., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100103 · Cited by 140
Ozato, Y., Kojima, Y., Kobayashi, Y., Hisamatsu, Y., Toshima, T., Yonemura, Y., Masuda, T., Kagawa, K., Goto, Y., Utou, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2022.111929 · Cited by 138
Precancerous colorectal lesions
CONTEDUCA, V., SANSONNO, D., RUSSI, S., & DAMMACCO, F. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2041 · Cited by 138
Bispecific Antibodies for Cancer Immunotherapy: Current Perspectives
Müller, D., & Kontermann, R. E. (2010) · BioDrugs · doi:10.2165/11530960-000000000-00000 · Cited by 137
Montagut, C., Argilés, G., Ciardiello, F., Poulsen, T. T., Dienstmann, R., Kragh, M., Kopetz, S., Lindsted, T., Ding, C., Vidal, J., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5245 · Cited by 135
Peng, Z., Ye, M., Ding, H., Feng, Z., & Hu, K. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03510-8 · Cited by 135
Morano, F., Raimondi, A., Pagani, F., Lonardi, S., Salvatore, L., Cremolini, C., Murgioni, S., Randon, G., Palermo, F., Antonuzzo, L., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02583 · Cited by 134
Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk
Jia, X., Burugula, B. B., Chen, V., Lemons, R. M., Jayakody, S., Maksutova, M., & Kitzman, J. O. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.12.003 · Cited by 133
Fakih, M., Sandhu, J. S., Lim, D. W., Li, X., Li, S., & Wang, C. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2022.7845 · Cited by 130
Toubaji, A., Achtar, M. S., Provenzano, M., Herrin, V. E., Behrens, R. J., Hamilton, M., Bernstein, S. A., Venzon, D. J., Gause, B. L., Marincola, F. M., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0477-6 · Cited by 129
Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
Kon, E., & Benhar, I. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.07.004 · Cited by 129
Mettu, N. B., Ou, F.-S., Zemla, T. J., Halfdanarson, T. R., Lenz, H.-J., Breakstone, R. A., Boland, P. M., Crysler, O. V., Wu, C., Nixon, A. B., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.49040 · Cited by 126
The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging
Fernandes, S. A., & Demetriades, C. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.707372 · Cited by 125
Amatu, A., Sartore-Bianchi, A., Moutinho, C., Belotti, A., Bencardino, K., Chirico, G., Cassingena, A., Rusconi, F., Esposito, A., Nichelatti, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3518 · Cited by 122
An Inflammatory Mediator, Prostaglandin E2, in Colorectal Cancer
Wang, D., & DuBois, R. N. (2013) · The Cancer Journal · doi:10.1097/ppo.0000000000000003 · Cited by 122
Tumor-derived circulating endothelial cell clusters in colorectal cancer
Cima, I., Kong, S. L., Sengupta, D., Tan, I. B., Phyo, W. M., Lee, D., Hu, M., Iliescu, C., Alexander, I., Goh, W. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7369 · Cited by 121
Alexander, W. (2016) · PubMed Central · Cited by 121
Epigenetic therapy in gastrointestinal cancer: the right combination
Abdelfatah, E., Kerner, Z. J., Nanda, N., & Ahuja, N. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16644247 · Cited by 118
Mottini, C., Napolitano, F., Li, Z., Gao, X., & Cardone, L. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.023 · Cited by 118
Calmeiro, J., Carrascal, M. A., Tavares, A. R., Ferreira, D. A., Gomes, C. M. F., Falcão, A. C., Cruz, M. T., & Neves, B. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020158 · Cited by 116
Foo, J., & Michor, F. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000557 · Cited by 115
Zhang, Z., Richmond, A. J., & Yan, C. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137353 · Cited by 115
Santandreu, F. M., Valle, A., Oliver, J., & Roca, P. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000331733 · Cited by 114
Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells
Qin, L., Lai, Y., Zhao, R., Wei, X., Weng, J., Lai, P., Li, B., Lin, S., Wang, S., Wu, Q., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0437-8 · Cited by 114
Duperret, E. K., Perales-Puchalt, A., Stoltz, R., G.H., H., Mandloi, N., Barlow, J., Chaudhuri, A., Sardesai, N. Y., & Weiner, D. B. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0283 · Cited by 108
Barth, R. J., Fisher, D. A., Wallace, P. K., Channon, J. Y., Noelle, R. J., Gui, J., & Ernstoff, M. S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2138 · Cited by 108
T-cell-based immunotherapy in colorectal cancer
Feng, M., Zhao, Z., Yang, M., Ji, J., & Zhu, D. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.10.040 · Cited by 107
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors
Duke, E. S., Bradford, D., Marcovitz, M., Amatya, A. K., Mishra-Kalyani, P. S., Nguyen, E., Price, L., Zirkelbach, J. F., Li, Y., Bi, Y., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0459 · Cited by 107
Gao, D., Li, C., Xie, X., Zhao, P., Wei, X., Sun, W., Liu, H.-C., Alexandrou, A. T., Jones, J., Zhao, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093886 · Cited by 106
Haag, G. M., Springfeld, C., Grün, B., Apostolidis, L., Zschäbitz, S., Dietrich, M., Berger, A.-K., Weber, T. F., Zoernig, I., Schaaf, M., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.03.017 · Cited by 105
Pellino, G., Gallo, G., Pallante, P., Capasso, R., Stefano, A. D., Maretto, I., Malapelle, U., Qiu, S., Nikolaou, S., Barina, A., et al. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/2397863 · Cited by 105
Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases
Rumilla, K. M., Schowalter, K. V., Lindor, N. M., Thomas, B. C., Mensink, K. A., Gallinger, S., Holter, S., Newcomb, P. A., Potter, J. D., Jenkins, M. A., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.11.011 · Cited by 102
Ogino, S., Odze, R. D., Kawasaki, T., Brahmandam, M., Kirkner, G. J., Laird, P. W., Loda, M., & Fuchs, C. S. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213266.84725.d0 · Cited by 102
Garralda, E., Sukari, A., Lakhani, N. J., Patnaik, A., Lou, Y., Im, S.-A., Golan, T., Geva, R., Wermke, M., de Miguel, M., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100639 · Cited by 101
Fleming-de-Moraes, C. D., Rocha, M. R., Tessmann, J. W., de Araújo, W. M., & Morgado‐Díaz, J. A. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2108690 · Cited by 101
Li, X., Hu, W., Zhou, J., Huang, Y., Peng, J., Yuan, Y., Yu, J., & Zheng, S. S. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0192-z · Cited by 99
Target selection of CAR T cell therapy in accordance with the TME for solid tumors.
Liu, B., Yan, L., & Zhou, M. (2019) · Europe PMC (PubMed Central) · Cited by 99
Porte, H., Triboulet, J. P., Kotelevets, L., Carrat, F., Prevot, S., Nordlinger, B., Gioia, Y. D., Wurtz, A. J., Comoglio, P. M., Gespach, C. P., et al. (1998) · PubMed · Cited by 99
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
Malmberg, K., Bryceson, Y. T., Carlsten, M., Andersson, S., Björklund, A. T., Björkström, N. K., Baumann, B. C., Fauriat, C., Alici, E., Dilber, M. S., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0492-7 · Cited by 98
Gao, S., Soares, F., Wang, S., Wong, C. C., Chen, H., Yang, Z., Liu, W., Go, M. Y. Y., Ahmed, M., Zeng, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01882-7 · Cited by 97
AMPK–a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?
Wang, N., Wang, B., Maswikiti, E. P., Yu, Y., Song, K., Ma, C., Han, X., Ma, H., Deng, X., Yu, R., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02011-5 · Cited by 97
Roelands, J. P., van der Ploeg, M., Ijsselsteijn, M. E., Dang, H., Boonstra, J. J., Hardwick, J. C. H., Hawinkels, L. J. A. C., Morreau, H. M., & de Miranda, N. F. C. C. (2022) · Gut · doi:10.1136/gutjnl-2022-327608 · Cited by 97
Genetic and clinical characterisation of familial adenomatous polyposis: a population based study
Al, M., Järvinen, H., & Peltomäki, P. (2002) · Gut · doi:10.1136/gut.50.6.845 · Cited by 97
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Tiptiri-Kourpeti, A., Spyridopoulou, K., Pappa, A., & Chlichlia, K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.05.004 · Cited by 96
Du, M., Gu, D., Xin, J., Peters, U., Song, M., Cai, G., Li, S., Ben, S., Meng, Y., Chu, H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100974 · Cited by 95
Wnt5a Suppresses Colon Cancer by Inhibiting Cell Proliferation and Epithelial–Mesenchymal Transition
Cheng, R.-F., Sun, B., Liu, Z., Zhao, X., Qi, L., Li, Y., & Gu, Q. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24566 · Cited by 95
Arena, S., Siravegna, G., Mussolin, B., Kearns, J. D., Wolf, B. B., Misale, S., Lazzari, L., Bertotti, A., Trusolino, L., Adjei, A. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5640 · Cited by 93
Cell cycle control of Wnt/β‐catenin signalling by conductin/axin2 through CDC20
Hadjihannas, M. V., Bernkopf, D. B., Brückner, M., & Behrens, J. (2012) · EMBO reports · doi:10.1038/embor.2012.12 · Cited by 91
Che, G., Yin, J., Wang, W., Luo, Y., Chen, Y., Yu, X., Wang, H., Liu, X., Chen, Z., Wang, X., et al. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101080 · Cited by 90
Self-citationA Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells
Martin, T. D., Cook, D. R., Choi, M. Y., Li, M. Z., Haigis, K. M., & Elledge, S. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.061 · Cited by 89
Yarchoan, M., Huang, C., Zhu, Q., Ferguson, A. K., Durham, J. N., Anders, R. A., Thompson, E. D., Rozich, N. S., Thomas, D. L., Nauroth, J. M., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2763 · Cited by 88
PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis
Liu, A., Yu, C., Qiu, C., Wu, Q., Huang, C., Li, X., She, X., Wan, K., Liu, L., Li, M., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02674-x · Cited by 87
Suarez‐Carmona, M., Williams, A., Schreiber, J., Hohmann, N., Prüfer, U., Krauß, J., Jäger, D., Frömming, A., Beyer, D., Eulberg, D., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002505 · Cited by 87
Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel
Ahn, S. B., Sharma, S., Mohamedali, A., Mahboob, S., Redmond, W. J., Pascovici, D., Wu, J. X., Zaw, T., Adhikari, S., Vaibhav, V., et al. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9255-z · Cited by 87
Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment
Yang, X., Guo, Y., Chen, C., Shao, B., Zhao, L., Zhou, Q., Liu, J., Wang, G., Yuan, W., & Sun, Z. (2021) · Immunology · doi:10.1111/imm.13397 · Cited by 86
Hazama, S., Nakamura, Y., Tanaka, H., Hirakawa, K., Tahara, K., Shimizu, R., Ozasa, H., Etoh, R., Sugiura, F., Okuno, K., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-108 · Cited by 86
Alsheridah, N., & Akhtar, S. (2018) · BMC Cancer · doi:10.1186/s12885-018-5132-9 · Cited by 86
Product review on the Anti-PD-L1 antibody atezolizumab
Shah, N. J., Kelly, W., Liu, S. V., Choquette, K., & Spira, A. I. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1403694 · Cited by 85
Segal, N. H., Cercek, A., Ku, G., Wu, A. J., Rimner, A., Khalil, D. N., Reidy-Lagunes, D., Cuaron, J., Yang, T. J., Weiser, M. R., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2474 · Cited by 84
Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection
Xie, L., Jiang, X., Li, Q., Sun, Z., Quan, W., Duan, Y., Li, D., & Chen, T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00247 · Cited by 84
Self-citationVäyrynen, J. P., Lau, M. C., Haruki, K., Väyrynen, S. A., Dias Costa, A., Borowsky, J., Zhao, M., Fujiyoshi, K., Arima, K., Twombly, T. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0071 · Cited by 83
Structural Chromosome Instability: Types, Origins, Consequences, and Therapeutic Opportunities
Siri, S. O., Martino, J., & Gottifredi, V. (2021) · Cancers · doi:10.3390/cancers13123056 · Cited by 83
Cohen, R., Bennouna, J., Meurisse, A., Tournigand, C., De La Fouchardière, C., Tougeron, D., Borg, C., Mazard, T., Chibaudel, B., Garcia-Larnicol, M.-L., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001499 · Cited by 81
Bao, X., Li, Q., Chen, J., Chen, D., Ye, C., Dai, X., Wang, Y., Li, X., Rong, X., Cheng, F., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-1101 · Cited by 80
Self-citationCirculating Tumor Cells: Strategies for Capture, Analyses, and Propagation
Agarwal, A., Balić, M., El‐Ashry, D., & Côté, R. J. (2018) · The Cancer Journal · doi:10.1097/ppo.0000000000000310 · Cited by 80
Choi, H., Chung, T., Kang, S., Lee, Y., Ko, J., Kim, J.-G., & Kim, C. (2006) · Glycobiology · doi:10.1093/glycob/cwj105 · Cited by 77
Kawakami, K., Matsunoki, A., Kaneko, M., Saito, K., Watanabe, G., & Minamoto, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01776.x · Cited by 75
The missing heritability of familial colorectal cancer
Schubert, S. A., Morreau, H. M., de Miranda, N. F. C. C., & van Wezel, T. (2019) · Mutagenesis · doi:10.1093/mutage/gez027 · Cited by 75
Monge, C., Xie, C., Myojin, Y., Coffman, K., Hrones, D. M., Wang, S., Hernandez, J. M., Wood, B. J., Levy, E. B., Juburi, I., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005640 · Cited by 75
Zou, Q., Wang, X., Ren, D., Hu, B., Tang, G., Zhang, Y., Huang, M., Pai, R. K., Buchanan, D. D., Win, A. K., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002671 · Cited by 74
MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17
Xu, K., Liang, X., Shen, K., Sun, L., Cui, D., Zhao, Y., Tian, J., Ni, L., & Liu, J. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.014 · Cited by 74
Wang, Y., He, T., Herman, J. G., Linghu, E., Yang, Y., Fuks, F., Zhou, F., Song, L., & Guo, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0417-4 · Cited by 74
Yang, X., Qiu, H., Wang, L., & Wang, X. (2023) · Journal of Medical Internet Research · doi:10.2196/44417 · Cited by 74
Self-citationAttenuated APC alleles produce functional protein from internal translation initiation
Goss, K. H., Trzepacz, C., Tuohy, T. M. F., & Groden, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112072199 · Cited by 72
Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years
Ehata, S., & Miyazono, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.883523 · Cited by 72
Endoscopic full-thickness resection of colorectal lesions: a systematic review and meta-analysis
Dolan, R. D., Bazarbashi, A. N., McCarty, T. R., Thompson, C. C., & Aihara, H. (2021) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2021.09.039 · Cited by 71
Impact of presymptomatic genetic testing on young adults: a systematic review
Godino, L., Turchetti, D., Jackson, L. M., Hennessy, C. H., & Skirton, H. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.153 · Cited by 71
Zhao, G., Liu, X., Liu, Y., Li, H., Ma, Y., Li, S., Zhu, Y., Miao, J., Xiong, S., Fei, S., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00643 · Cited by 71
Yu, C., Luo, D., Yu, J., Zhang, M., Zheng, X., Xu, G., Wang, J., Wang, H., Xu, Y., Jiang, K., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02077-w · Cited by 70
Robinson, P. S., Thomas, L. E., Abascal, F., Jung, H., Harvey, L. M. R., West, H. D., Ólafsson, S., Lee, B. C. H., Coorens, T. H. H., Lee-Six, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31341-0 · Cited by 70
Current Microsatellite Instability Testing in Management of Colorectal Cancer
Sun, B. L. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.08.001 · Cited by 69
Gao, J., Wu, Z., Zhao, M., Zhang, R., Li, M., Sun, D., Cheng, H., Qi, X., Shen, Y., Xu, Q., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.006 · Cited by 69
Research works printed but not linked: 4
- Charifa, A., Jamil, R. T. & Zhang, X. Gardner syndrome. (2018). 29493967
- Garralda, E. et al. (Wolters Kluwer Health, 2021).
- Troyanska, O. & Reich, R. Pacific Symposium on Biocomputing 2022. World Sci, 175–186 (2022).
- Mnih, V., Heess, N. & Graves, A. Recurrent models of visual attention. Adv. Neural Inf. Process Syst. 2204–2212 (2014).
Cited by
Unveiling the link between chronic inflammation and cancer
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100347 · Cited by 109
Galasso, L., Termite, F., Mignini, I., Esposto, G., Borriello, R., Vitale, F., Nicoletti, A., Paratore, M., Ainora, M. E., Gasbarrini, A., et al. (2025) · Cancers · doi:10.3390/cancers17030368 · Cited by 90
Uti, D. E., Atangwho, I. J., Alum, E. U., Ntaobeten, E., Obeten, U. N., Bawa, I., Agada, S. A., Ukam, C. I.-O., & Egbung, G. E. (2025) · Discover Nano · doi:10.1186/s11671-025-04248-0 · Cited by 82
Bautista, J., Maceiras, M. L., Hidalgo‐Tinoco, C., Guerra-Guerrero, A., Betancourt-Velarde, A., & López‐Cortés, A. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00883-8 · Cited by 77
Pang, B., & Wu, H. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02623-5 · Cited by 79
Metadata
- Authors
- Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B.
- Affiliations
- Chongqing University (CN)
- Chongqing Medical University (CN)
- Army Medical University (CN)
- Chongqing Municipal Health Commission (CN)
- Corresponding author
- Xu, Bo
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-10-07
- Volume
- 9
- Issue
- 1
- Pages
- 266-266
- ISSN
- 2059-3635 (ISSN-L)
- PMC
- PMC11456611
- OpenAlex
- W4403163174
- Cited by
- 546
- References
- 537
- Citations by year
- 2026: 275 · 2025: 263 · 2024: 7
- FWCI
- 29.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (61906022, 82203066)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- colorectal cancer, signal transduction, oncogenic signaling, colorectal cancer pathogenesis, colorectal cancer progression, targeted therapy, immunotherapy, epigenomics, microbiome, patient stratification
- MeSH terms
- Humans, Colorectal Neoplasms, Signal Transduction, Precision Medicine, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.